European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document.

Breast cancer is a major cause of suffering and death and is of significant concern to many women. Early detection of breast cancer by systematic mammography screening can find lesions for which treatment is more effective and generally more favourable for quality of life. The potential harm caused by mammography includes the creation of unnecessary anxiety and morbidity, inappropriate economic cost and the use of ionising radiation. It is for this reason that the strongest possible emphasis on quality control and quality assurance is required. Development of the European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis has been an initiative within the Europe Against Cancer Programme. The fourth edition of the multidisciplinary guidelines was published in 2006 and comprises approximately 400 pages divided into 12 chapters prepared by >200 authors and contributors. The multidisciplinary editorial board has prepared a summary document to provide an overview of the fundamental points and principles that should support any quality screening or diagnostic service. This document includes a summary table of key performance indicators and is presented here in order to make these principles and standards known to a wider scientific community.

[1]  K. Siziopikou,et al.  Rosen's Breast Pathology , 2009 .

[2]  S. Holm Informed Consent: Ethical and Legal Issues , 2009 .

[3]  A. Sahin,et al.  Mucinous Lesions of the Breast. , 2009, Surgical pathology clinics.

[4]  C. Quinn,et al.  Columnar cell lesions of the breast , 2007, Histopathology.

[5]  J. Ferlay,et al.  Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  Ehsan Samei,et al.  Assessment of display performance for medical imaging systems: executive summary of AAPM TG18 report. , 2005, Medical physics.

[7]  A. Vincent-Salomon,et al.  Histological margin assessment for breast ductal carcinoma in situ: precision and implications , 2004, Modern Pathology.

[8]  J. Wesseling,et al.  Axillary recurrence after sentinel lymph node biopsy. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[9]  K. Kahn,et al.  Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer care quality. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  M. Piccart,et al.  The Hamburg statement: the partnership driving the European agenda on breast cancer. , 2004, European Journal of Cancer.

[11]  S. Ciatto,et al.  Prognostic impact of the early detection of metachronous contralateral breast cancer. , 2004, European journal of cancer.

[12]  J. Peterse,et al.  Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology , 2004, Journal of Clinical Pathology.

[13]  D. Giorgi,et al.  Monitoring surgical treatment of screen-detected breast lesions in Italy. , 2004, European journal of cancer.

[14]  G. Cserni A model for determining the optimum histology of sentinel lymph nodes in breast cancer , 2004, Journal of Clinical Pathology.

[15]  S. Barni,et al.  Effects of media information on cancer patients' opinions, feelings, decision‐making process and physician‐patient communication , 2004, Cancer.

[16]  R Holland,et al.  Diagnostic accuracy for different strategies of image-guided breast intervention in cases of nonpalpable breast lesions , 2004, British Journal of Cancer.

[17]  J. Hoffmann Is it time for a paradigm shift in the training of breast surgeons as a sub-speciality? , 2004, Breast.

[18]  A. Gown,et al.  Accuracy and precision in HER2/neu testing in breast cancer: are we there yet? , 2004, Human pathology.

[19]  A. Hanby,et al.  Agreement between preoperative core needle biopsy and postoperative invasive breast cancer histopathology is not dependent on the amount of clinical material obtained , 2004, Journal of Clinical Pathology.

[20]  Peter C Gøtzsche,et al.  Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study , 2004, BMJ : British Medical Journal.

[21]  C. Theisen In different cultures, cancer screening presents challenges. , 2004, Journal of the National Cancer Institute.

[22]  L. Sobin,et al.  Classification of isolated tumor cells , 2003, Cancer.

[23]  M. Buchanan The role of women's advocacy groups in breast cancer. , 2003, Breast.

[24]  Per Skaane,et al.  Population-based mammography screening: comparison of screen-film and full-field digital mammography with soft-copy reading--Oslo I study. , 2003, Radiology.

[25]  Karla Kerlikowske,et al.  Comparison of screening mammography in the United States and the United kingdom. , 2003, JAMA.

[26]  C. Baines Mammography screening: are women really giving informed consent? , 2003, Journal of the National Cancer Institute.

[27]  J. Carr,et al.  Biopsy Needle Technique and the Accuracy of Diagnosis of Atypical Ductal Hyperplasia for Mammographic Abnormalities , 2003, The American surgeon.

[28]  J. Peterse,et al.  Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. , 2003, European journal of cancer.

[29]  Byllye Y. Avery,et al.  The road to advocacy--searching for the rainbow. , 2003, American journal of public health.

[30]  P. Adab,et al.  Randomised controlled trial of the effect of evidence based information on women’s willingness to participate in cervical cancer screening , 2003, Journal of epidemiology and community health.

[31]  A. Edwards,et al.  Women need better information about routine mammography , 2003, BMJ : British Medical Journal.

[32]  M. Baum Is it time for a paradigm shift in the training of breast surgeons as a sub-speciality?! , 2003, Breast.

[33]  A. Vincent-Salomon,et al.  Columnar Cell Lesions of the Breast , 2003, Advances in anatomic pathology.

[34]  L J Schultze Kool,et al.  Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. , 2003, European journal of cancer.

[35]  M. Hammond,et al.  Conference summary, Strategic Science symposium. Her-2/neu testing of breast cancer patients in clinical practice. , 2003, Archives of pathology & laboratory medicine.

[36]  A. Vincent-Salomon,et al.  Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French Multicentre GEFPICS * Study , 2003, Histopathology.

[37]  J. Bartlett,et al.  The clinical evaluation of HER‐2 status: which test to use? , 2003, The Journal of pathology.

[38]  M. Dowsett,et al.  Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER‐2 in 426 breast carcinomas from 37 centres , 2003, The Journal of pathology.

[39]  E. Zanon,et al.  Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management , 2003, British Journal of Cancer.

[40]  E. Cronin,et al.  Invasive Mammary Carcinoma After Immediate and Short-Term Follow-up for Lobular Neoplasia on Core Biopsy , 2003, The American journal of surgical pathology.

[41]  M. Dowsett,et al.  Current Perspectives on HER2 Testing: A Review of National Testing Guidelines , 2003, Modern Pathology.

[42]  I. Ellis,et al.  Correlation of Histologic Prognostic Factors in Core Biopsies and Therapeutic Excisions of Invasive Breast Carcinoma , 2003, The American journal of surgical pathology.

[43]  G. Lawrence,et al.  The National Health Service Breast Screening Programme and British Association of Surgical Oncology audit of quality assurance in breast screening 1996–2001 , 2003, The British journal of surgery.

[44]  P. Butow,et al.  Medical tests: women's reported and preferred decision‐making roles and preferences for information on benefits, side‐effects and false results , 2002, Health expectations : an international journal of public participation in health care and health policy.

[45]  W. P. Evans,et al.  Percutaneous core needle biopsy of radial scars of the breast: when is excision necessary? , 2002, AJR. American journal of roentgenology.

[46]  M. Risio,et al.  HER2 testing and correlation with efficacy of trastuzumab therapy. , 2002, Oncology.

[47]  I. Ellis,et al.  HER-2 in breast cancer--methods of detection, clinical significance and future prospects for treatment. , 2002, Critical reviews in oncology/hematology.

[48]  Anthony Rhodes,et al.  Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries. , 2002, American journal of clinical pathology.

[49]  S. Schnitt,et al.  Nonmalignant Lesions in Breast Core Needle Biopsies: To Excise or Not to Excise? , 2002, The American journal of surgical pathology.

[50]  J. Bartlett,et al.  Fluorescence in situ hybridization in paraffin tissue sections , 2002, Molecular biotechnology.

[51]  Walter Huda,et al.  How good is the ACR accreditation phantom for assessing image quality in digital mammography? , 2002, Academic radiology.

[52]  H. Verkooijen Diagnostic accuracy of stereotactic large‐core needle biopsy for nonpalpable breast disease: Results of a multicenter prospective study with 95% surgical confirmation , 2002, International journal of cancer.

[53]  Peter A Kaufman,et al.  Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831. , 2002, Journal of the National Cancer Institute.

[54]  Greg Yothers,et al.  Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience. , 2002, Journal of the National Cancer Institute.

[55]  G. Bratthauer,et al.  Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. , 2002, Human pathology.

[56]  Hermann Herbst,et al.  Common Adult Stem Cells in the Human Breast Give Rise to Glandular and Myoepithelial Cell Lineages: A New Cell Biological Concept , 2002, Laboratory Investigation.

[57]  T. Davis,et al.  Health Literacy and Cancer Communication , 2002, CA: a cancer journal for clinicians.

[58]  Umberto Veronesi,et al.  Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast April 19–22, 2001, Philadelphia, PA, USA , 2002 .

[59]  H. de Vries,et al.  Tailored versus general information on early detection of cancer: a comparison of the reactions of Dutch adults and the impact on attitudes and behaviors. , 2002, Health education research.

[60]  A. Hanby,et al.  Mitotic counts provide additional prognostic information in grade II mammary carcinoma , 2002, The Journal of pathology.

[61]  M. Bruijnzeels,et al.  Intercultural communication in general practice. , 2002, European journal of public health.

[62]  C. Ramsay,et al.  Mass media interventions: effects on health services utilisation. , 2002, The Cochrane database of systematic reviews.

[63]  J. Stinès,et al.  Contrôle de qualité : Du conventionnel au numérique , 2002 .

[64]  B. Jasani,et al.  A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer. , 2002, American journal of clinical pathology.

[65]  Catherine Kim Ly,et al.  SoftCopy Display Quality Assurance Program at Texas Children's Hospital. , 2002, Journal of digital imaging.

[66]  M. Greco,et al.  Quality control in prophylactic mastectomy for women at high risk of breast cancer. , 2002, European journal of cancer.

[67]  K. Dickersin,et al.  Newspaper Reporting of Screening Mammography , 2002, Annals of Internal Medicine.

[68]  J Austoker,et al.  Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance. , 2001, Journal of public health medicine.

[69]  A. Luini,et al.  Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma , 2001, Cancer.

[70]  J. Going,et al.  Scoring nuclear pleomorphism in breast cancer , 2001, Histopathology.

[71]  D B Plewes,et al.  Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[72]  A Coulter Patient-centered decision making: empowering women to make informed choices. , 2001, Women's health issues : official publication of the Jacobs Institute of Women's Health.

[73]  R. Warren,et al.  Screening women at high risk of breast cancer on the basis of evidence. , 2001, European journal of radiology.

[74]  I. Ellis,et al.  Growth pattern of ductal carcinoma in situ (DCIS): a retrospective analysis based on mammographic findings , 2001, British Journal of Cancer.

[75]  A. Raffle,et al.  Information about screening – is it to achieve high uptake or to ensure informed choice? , 2001, Health expectations : an international journal of public participation in health care and health policy.

[76]  M. Parker The ethics of evidence‐based patient choice , 2001, Health expectations : an international journal of public participation in health care and health policy.

[77]  A. Sowden,et al.  Increasing informed uptake and non‐uptake of screening: evidence from a systematic review , 2001, Health expectations : an international journal of public participation in health care and health policy.

[78]  S. Sonnad,et al.  Mammography messages in popular media: implications for patient expectations and shared clinical decision‐making , 2001, Health expectations : an international journal of public participation in health care and health policy.

[79]  H A Lehr,et al.  Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. , 2001, American journal of clinical pathology.

[80]  D. Page,et al.  Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. , 2001, Human pathology.

[81]  P. Rosen Rosen's Breast Pathology , 2001 .

[82]  S. Schnitt Breast Cancer in the 21st Century: Neu Opportunities and Neu Challenges , 2001, Modern Pathology.

[83]  L. Bobrow,et al.  Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays. , 2001, American journal of clinical pathology.

[84]  N. Perry Quality assurance in the diagnosis of breast disease. EUSOMA Working Party. , 2001, European journal of cancer.

[85]  Julie Cooke,et al.  CLINICAL GUIDELINES FOR BREAST CANCER SCREENING ASSESSMENT , 2001 .

[86]  I. Ellis,et al.  Recommendations for HER2 testing in the UK , 2000, Journal of clinical pathology.

[87]  C. Lee,et al.  Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? , 2000, Radiology.

[88]  C. J. Kotre,et al.  Additional factors for the estimation of mean glandular breast dose using the UK mammography dosimetry protocol. , 2000, Physics in medicine and biology.

[89]  L. Irwig,et al.  Telling people about screening programmes and screening test results: how can we do it better? , 2000, Journal of medical screening.

[90]  L. Sobin,et al.  Classification of isolated tumor cells and micrometastasis , 2000 .

[91]  D Barnes,et al.  Immunohistochemical detection of steroid receptors in breast cancer: a working protocol , 2000, Journal of clinical pathology.

[92]  Richard Sylvester,et al.  Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. , 2000, Journal of the National Cancer Institute.

[93]  B. Cady A contemporary view of axillary dissection. , 2000, Annals of surgery.

[94]  L. Liberman,et al.  Cost-effectiveness of stereotactic 11-gauge directional vacuum-assisted breast biopsy. , 2000, AJR. American journal of roentgenology.

[95]  F. Bull,et al.  Are tailored health education materials always more effective than non-tailored materials? , 2000, Health education research.

[96]  L Collette,et al.  The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[97]  A. Luini,et al.  Use of technetium-99m-labeled colloid albumin for preoperative and intraoperative localization of nonpalpable breast lesions. , 2000, Journal of the American College of Surgeons.

[98]  G. Soete,et al.  Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[99]  R. Walker The significance of histological determination of HER-2 status in breast cancer. , 2000, Breast.

[100]  R. Grilli,et al.  Does provision of an evidence‐based information change public willingness to accept screening tests? , 2000, Health expectations : an international journal of public participation in health care and health policy.

[101]  R. M. Wilson Screening for breast and cervical cancer as a common cause for litigation , 2000, BMJ : British Medical Journal.

[102]  E. Frenkel,et al.  Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays , 2000, Journal of clinical pathology.

[103]  A. Wolff,et al.  Primary systemic therapy in operable breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[104]  A. Hart,et al.  Primary axillary radiotherapy as axillary treatment in breast‐conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes , 2000, Cancer.

[105]  B. Fowble,et al.  Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? , 2000, International journal of radiation oncology, biology, physics.

[106]  M. R. del Turco,et al.  General Practitioners and Mammographic Screening Uptake: Influence of Different Modalities of General Practitioner Participation , 2000, Tumori.

[107]  G. Schwartz,et al.  Consensus Conference on the Classification of Ductal Carcinoma of the Breast, April 22–25, 1999 , 2000, The breast journal.

[108]  J. Peterse,et al.  Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853 , 2000, The Lancet.

[109]  R. Prescott,et al.  Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial , 2000, The British journal of surgery.

[110]  E. Thurfjell,et al.  Predictors of non‐attendance in a population‐based mammography screening programme; socio‐demographic factors and aspects of health behaviour , 2000, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[111]  D. Page,et al.  Benign transport of breast epithelium into axillary lymph nodes after biopsy. , 2000, American journal of clinical pathology.

[112]  A. Giuliano,et al.  Role of sentinel lymph node dissection in breast cancer , 2000, Annals of medicine.

[113]  I. Smith,et al.  Neoadjuvant chemotherapy for breast cancer , 2000, Annals of medicine.

[114]  G. Schwartz,et al.  Consensus Conference on the Treatment of In Situ Ductal Carcinoma of the Breast, April 22-25, 1999. , 2000, Cancer.

[115]  B. Cady,et al.  The surgeon's role in outcome in contemporary breast cancer. , 2000, Surgical oncology clinics of North America.

[116]  A. Recht Should irradiation replace dissection for patients with breast cancer with clinically negative axillary lymph nodes? , 1999, Journal of surgical oncology.

[117]  P. Rosen Columnar cell hyperplasia is associated with lobular carcinoma in situ and tubular carcinoma. , 1999, The American journal of surgical pathology.

[118]  N. Segnan,et al.  [Compliance, conscious participation, and informed consent in tumor screening programs]. , 1999, Epidemiologia e prevenzione.

[119]  F. E. White,et al.  Fine needle aspiration cytology in the UK breast screening programme: a national audit of results. , 1999, Breast.

[120]  J. Austoker Gaining informed consent for screening , 1999, BMJ.

[121]  S. Ciatto,et al.  Proficiency test for screening mammography: results for 117 volunteer Italian radiologists , 1999, Journal of medical screening.

[122]  K. Kahn,et al.  Proposed agenda for the measurement of quality-of-care outcomes in oncology practice. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[123]  D. Jaffray,et al.  A ghost story: spatio-temporal response characteristics of an indirect-detection flat-panel imager. , 1999, Medical physics.

[124]  M. Overgaard,et al.  Overview of randomized trials in high risk breast cancer patients treated with adjuvant systemic therapy with or without postmastectomy irradiation. , 1999, Seminars in radiation oncology.

[125]  J. Nottingham,et al.  Invited reviewBridging the knowledge gap and communicating uncertainties for informed consent in cervical cytology screening; we need unbiased information and a culture change , 1999, Cytopathology : official journal of the British Society for Clinical Cytology.

[126]  H. D. de Koning,et al.  Psychosocial predictors of first attendance for organised mammography screening , 1999, Journal of medical screening.

[127]  Jean-Pierre Moy,et al.  How does real offset and gain correction affect the DQE in images from x-ray flat detectors? , 1999, Medical Imaging.

[128]  S. Martino,et al.  The influence of margin width on local control of ductal carcinoma in situ of the breast. , 1999, The New England journal of medicine.

[129]  J. Meyer,et al.  Fibrous nodules found at large-core needle biopsy of the breast: imaging features. , 1999, Radiology.

[130]  C K Osborne,et al.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[131]  R. Samant,et al.  Staging investigations in patients with breast cancer: the role of bone scans and liver imaging. , 1999, Archives of surgery.

[132]  A. Hart,et al.  Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy , 1999, Cancer.

[133]  R. Severson,et al.  Axillary lymph node metastases associated with small invasive breast carcinomas , 1999, Cancer.

[134]  Liesbeth Jansen,et al.  Lymphatic mapping and sentinel lymph node biopsy in breast cancer , 1999, European Journal of Nuclear Medicine.

[135]  G. Colditz,et al.  Radial scars in benign breast-biopsy specimens and the risk of breast cancer. , 1999, The New England journal of medicine.

[136]  P. D. Britton,et al.  Fine needle aspiration or core biopsy , 1999 .

[137]  P. Britton,et al.  Needle biopsy in the NHS breast screening programme 1996/97: how much and how accurate? , 1999 .

[138]  A Coulter,et al.  Sharing decisions with patients: is the information good enough? , 1999, BMJ.

[139]  G. MacGrogan,et al.  Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS). , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[140]  E. Arkin Cancer risk communication-what we know. , 1999, Journal of the National Cancer Institute. Monographs.

[141]  L. Holmberg,et al.  Florence statement on breast cancer, 1998 forging the way ahead for more research on and better care in breast cancer. , 1999, European journal of cancer.

[142]  R. Blamey The British Association of Surgical Oncology Guidelines for surgeons in the management of symptomatic breast disease in the UK (1998 revision). BASO Breast Specialty Group. , 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[143]  S. Schnitt,et al.  Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. , 1998, The American journal of surgical pathology.

[144]  C Kimme-Smith,et al.  Establishing minimum performance standards, calibration intervals, and optimal exposure values for a whole breast digital mammography unit. , 1998, Medical physics.

[145]  J Austoker,et al.  Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment. , 1998, Journal of public health medicine.

[146]  Mireille J. M. Broeders,et al.  Breast cancer screening programmes in 22 countries: current policies, administration and guidelines , 1998 .

[147]  L. Beex,et al.  Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance. , 1998, European journal of cancer.

[148]  W F Velicer,et al.  Increasing mammography among women aged 40-74 by use of a stage-matched, tailored intervention. , 1998, Preventive medicine.

[149]  Anna L. Brown,et al.  Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[150]  A Coulter,et al.  Evidence based patient information , 1998, BMJ.

[151]  F. Tavassoli,et al.  Mammary ductal carcinoma in Situ with microinvasion , 1998, Cancer.

[152]  L. G. Doak,et al.  Improving comprehension for cancer patients with low literacy skills: Strategies for clinicians , 1998, CA: a cancer journal for clinicians.

[153]  C. de Wolf,et al.  European guidelines for quality assurance in the surgical management of mammographically detected lesions. , 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[154]  T A Sheldon,et al.  Evidence-Informed Patient Choice: Practical Issues of Involving Patients in Decisions About Health Care Technologies , 1998, International Journal of Technology Assessment in Health Care.

[155]  J. Costantino,et al.  Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[156]  M. Silverstein Ductal carcinoma in situ of the breast , 1997, The British journal of surgery.

[157]  E. Samei,et al.  A method for measuring the presampled MTF of digital radiographic systems using an edge test device. , 1998, Medical physics.

[158]  R. Gupta,et al.  Fine needle aspiration cytology of tubular carcinoma of the breast. , 1997, Acta cytologica.

[159]  K. Joshi,et al.  Cytology of "significant" breast ductal proliferations. , 1997, Acta cytologica.

[160]  A. Raffle,et al.  Informed participation in screening is essential , 1997, BMJ.

[161]  A. Hanlon,et al.  Identification of women with T1‐T2 breast cancer at low risk of positive axillary nodes , 1997, Journal of surgical oncology.

[162]  N. O’higgins,et al.  Principles and guidelines for surgeons--management of symptomatic breast cancer. European Society of Surgical Oncology. , 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[163]  I Tocino,et al.  Cost-effectiveness of stereotactic core needle biopsy: analysis by means of mammographic findings. , 1997, Radiology.

[164]  S. Shousha,et al.  Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma. , 1997, Journal of clinical pathology.

[165]  N. O’higgins,et al.  Principles and guidelines for surgeonsmanagement of symptomatic breast cancer , 1997 .

[166]  W. Böcker,et al.  [Ductal hyperplasia and ductal carcinoma in situ. Definition--classification--differential diagnosis]. , 1997, Der Pathologe.

[167]  H. Bartelink,et al.  Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European Organization for Research and Treatment of Cancer Randomized Phase III Trial. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[168]  R. Sainsbury,et al.  Inequalities in breast cancer care and outcome. , 1997, British Journal of Cancer.

[169]  N. Perry,et al.  European Guidelines for Quality Assurance in Mammography Screening , 1996 .

[170]  I. Fentiman,et al.  Comparison of the surgical procedures for breast conserving treatment of early breast cancer in seven EORTC centres. , 1996, European journal of cancer.

[171]  R. Hruban,et al.  Lessons from mammographic-histopathologic correlation of large-core needle breast biopsy. , 1996, Radiographics : a review publication of the Radiological Society of North America, Inc.

[172]  Marshall Kg Prevention. How much harm? How much benefit? 4. The ethics of informed consent for preventive screening programs. , 1996 .

[173]  N. Kapucuoglu,et al.  The effects of chemotherapy on breast cancer tissue in locally advanced breast cancer , 1996, Histopathology.

[174]  R. Pinto,et al.  Infarction after fine needle aspiration. A report of four cases. , 1996, Acta cytologica.

[175]  M. Cunningham,et al.  Factors affecting outcome of patients with impalpable breast cancer detected by breast screening , 1996, The British journal of surgery.

[176]  Geraldine F. Hoemke,et al.  Fundamentals of Mammography , 1996 .

[177]  Barbara L. Smith,et al.  Developing a prognostic index for ductal carcinoma in situ of the breast: Are we there yet? , 1996, Cancer.

[178]  J. Forbes,et al.  Two sequential randomized trials of community participation to recruit women for mammographic screening. , 1996, Preventive medicine.

[179]  Israel Pz The revolution in breast biopsy: where is the surgeon? , 1996 .

[180]  L. Yeoman,et al.  Radiographically guided fine needle aspiration cytology and core biopsy in the assessment of impalpable breast lesions , 1996 .

[181]  C. Loughran,et al.  Combined stereotactic wide-core needle biopsy and fine-needle aspiration cytology in the assessment of impalpable mammographic abnormalities detected in a breast-screening programme , 1996 .

[182]  W. P. Evans,et al.  Percutaneous core biopsy of the breast: effect of operator experience and number of samples on diagnostic accuracy. , 1996, AJR. American journal of roentgenology.

[183]  G. Hortobagyi,et al.  Locally advanced breast cancer. , 1999, Hematology/oncology clinics of North America.

[184]  C. Gillis,et al.  Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland , 1996, BMJ.

[185]  G. Poulard,et al.  [Diabetic mastopathy with epithelioid fibroblasts :differential diagnosis from an infiltrating lobular carcinoma of the breast. Report of two cases]. , 1996, Annales de pathologie.

[186]  P. Israel The revolution in breast biopsy: where is the surgeon? , 1996, The American surgeon.

[187]  S. Schnitt,et al.  Local control following breast-conserving surgery for invasive cancer: results of clinical trials. , 1995, Journal of the National Cancer Institute.

[188]  Linda S. Lee Fundamentals of Mammography , 1995 .

[189]  S. Pinder,et al.  Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma , 1995, Histopathology.

[190]  M. J. Silverstein,et al.  Prognostic classification of breast ductal carcinoma-in-situ , 1995, The Lancet.

[191]  Tavassoli Fa,et al.  Pseudoinvasion in intraductal carcinoma. , 1995 .

[192]  L. Liberman,et al.  Displacement of carcinomatous epithelium in surgical breast specimens following stereotaxic core biopsy. , 1995, American journal of clinical pathology.

[193]  H. Thornton Screening for breast cancer , 1995, BMJ.

[194]  R W Blamey,et al.  A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. , 1995, Human pathology.

[195]  P. Ganz Advocating for the woman with breast cancer , 1995, CA: a cancer journal for clinicians.

[196]  L. Liberman,et al.  Stereotaxic core biopsy of breast carcinoma: accuracy at predicting invasion. , 1995, Radiology.

[197]  F. Tavassoli,et al.  Pseudoinvasion in intraductal carcinoma. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[198]  C. Wells Quality assurance in breast cancer screening cytology: a review of the literature and a report on the U.K. national cytology scheme. , 1995, European journal of cancer.

[199]  U. Veronesi,et al.  Surgical pitfalls after preoperative chemotherapy in large size breast cancer. , 1994, European Journal of Surgical Oncology.

[200]  G. W. Eklund,et al.  Percutaneous large-core breast biopsy: a multi-institutional study. , 1994, Radiology.

[201]  J. Austoker,et al.  Written Information Needs of Women Who are Recalled for Further Investigation of Breast Screening: Results of a Multicentre Study , 1994, Journal of medical screening.

[202]  J. Chan,et al.  Histologic Changes in the Breast after Fine‐Needle Aspiration , 1994, The American journal of surgical pathology.

[203]  S. Levitt The importance of locoregional control in the treatment of breast cancer and its impact on survival , 1994, Cancer.

[204]  F. Tavassoli,et al.  Intraductal apocrine carcinoma: a clinicopathologic study of 37 cases. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[205]  A. Douglas-Jones,et al.  Role of fine‐needle aspiration cytology and needle‐core biopsy in the diagnosis of lobular carcinoma of the breast , 1994, The British journal of surgery.

[206]  M. Cranor,et al.  Epithelial Displacement in Surgical Breast Specimens Following Needling Procedures , 1994, The American journal of surgical pathology.

[207]  K C Young,et al.  Mammographic film density and detection of small breast cancers. , 1994, Clinical radiology.

[208]  D. Slamon,et al.  Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression. , 1994, Cancer research.

[209]  A. Nicholson,et al.  Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas , 1994, The Lancet.

[210]  W. Dupont,et al.  Ductal carcinoma in situ of the breast with apocrine cytology: definition of a borderline category. , 1994, Human Pathology.

[211]  S. Pinder,et al.  Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long‐term follow‐up , 1994, Histopathology.

[212]  L L Fajardo,et al.  Stereotactic fine-needle aspiration cytology of nonpalpable breast lesions: an analysis of 258 consecutive aspirates. , 1994, American journal of surgery.

[213]  F. Abdul-Karim,et al.  Mucinous lesions of the breast. A pathological continuum. , 1993, Pathology, research and practice.

[214]  A. Buzdar,et al.  Evaluation of patients after primary therapy for early breast cancer , 1993 .

[215]  T Albert,et al.  How readable are practice leaflets? , 1992, BMJ.

[216]  G. Hortobagyi,et al.  Treatment of locally advanced breast cancer. , 1992, Seminars in oncology.

[217]  J. Meyer Value of large-core biopsy of occult breast lesions. , 1992, AJR. American journal of roentgenology.

[218]  Gini Wentz,et al.  Mammography for Radiologic Technologists , 1992 .

[219]  Fatteneh Ed. Tavassoli,et al.  Pathology of The Breast , 1992 .

[220]  L. Skoog,et al.  Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Stockholm Breast Cancer Study Group. , 1992, Acta oncologica.

[221]  G. W. Eklund,et al.  The art of mammographic positioning. , 1992, Radiologic clinics of North America.

[222]  Kunio Doi,et al.  A simple method for determining the modulation transfer function in digital radiography , 1992, IEEE Trans. Medical Imaging.

[223]  W. Dupont,et al.  Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. , 1991, Human pathology.

[224]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[225]  D. Page Atypical hyperplasia, narrowly and broadly defined. , 1991, Human pathology.

[226]  X. Tyler,et al.  Fine Needle Aspiration Cytology of Collagenous Spherulosis of the Breast , 1991, Cytopathology : official journal of the British Society for Clinical Cytology.

[227]  L. Kaufman,et al.  Comparison of cell growth in different parts of breast cancers , 1990, Histopathology.

[228]  C. Wells,et al.  Spherical connective tissue inclusions in epithelial hyperplasia of the breast ("collagenous spherulosis"). , 1990, Journal of clinical pathology.

[229]  A. Evans,et al.  A microglandular adenosis‐like lesion simulating tubular adenocarcinoma of the breast. A case report with cytological and histological appearances , 1990, Cytopathology : official journal of the British Society for Clinical Cytology.

[230]  W. Dupont,et al.  Anatomic markers of human premalignancy and risk of breast cancer , 1990, Cancer.

[231]  D. Dance Monte Carlo calculation of conversion factors for the estimation of mean glandular breast dose. , 1990, Physics in medicine and biology.

[232]  M. Lagios Duct carcinoma in situ. Pathology and treatment. , 1990, The Surgical clinics of North America.

[233]  M. Silverstein,et al.  Intraductal carcinoma of the breast (208 cases): Clinical factors influencing treatment choice , 1990, Cancer.

[234]  I. Andersson,et al.  Stereotactic fine-needle aspiration for cytologic diagnosis of nonpalpable breast lesions. , 1990, AJR. American journal of roentgenology.

[235]  J. Hendriks,et al.  Extent, distribution, and mammographic/ histological correlations of breast ductal carcinoma in situ , 1990, The Lancet.

[236]  R. Millis,et al.  Radiation and other pathological changes in breast tissue after conservation treatment for carcinoma. , 1990, Journal of clinical pathology.

[237]  K. Lindholm,et al.  Aspiration cytology of tubular breast carcinoma. , 1990, Acta cytologica.

[238]  N. Sneige,et al.  Fine-needle aspiration cytology of metastatic neoplasms in the breast. , 1989, American journal of clinical pathology.

[239]  J. Lamb,et al.  Influence of cancer histology on the success of fine needle aspiration of the breast. , 1989, Journal of clinical pathology.

[240]  D. Page,et al.  Abstract digest , 1989, American Journal of Clinical Pathology.

[241]  J. Peterse,et al.  Atypia in fine-needle aspiration cytology of the breast: a histologic follow-up study of 301 cases. , 1989, Seminars in diagnostic pathology.

[242]  P. Vassilakos,et al.  A simple method for estrogen receptor antigen preservation in cytologic specimens containing breast carcinoma cells , 1989, Diagnostic cytopathology.

[243]  R. Wood,et al.  Cytodiagnosis and other methods of biopsy in the modern management of breast cancer. , 1989, Seminars in surgical oncology.

[244]  R. Erlandson,et al.  Cystic hypersecretory hyperplasia and cystic hypersecretory duct carcinoma of the breast. Pathology, therapy, and follow‐up of 39 patients , 1988, Cancer.

[245]  W. Dupont,et al.  Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk. , 1988, Human pathology.

[246]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[247]  J. Lamb,et al.  Fine‐needle aspiration of breast cancer: Relationship of clinical factors to cytology results in 689 primary malignancies , 1986, Cancer.

[248]  P. Rosen Mucocele-like Tumors of the Breast , 1986, The American journal of surgical pathology.

[249]  E. Engelsman,et al.  Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical study. , 1985, International journal of radiation oncology, biology, physics.

[250]  David L. Page,et al.  Atypical hyperplastic lesions of the female breast. A long‐term follow‐up study , 1985, Cancer.

[251]  E. Fisher,et al.  Intraductal signet ring carcinoma. A hitherto undescribed form of intraductal carcinoma of the breast , 1985, Cancer.

[252]  Kenneth G. Lisk SMPTE Test Pattern For Certification Of Medical Diagnostic Display Devices , 1984, Medical Imaging.

[253]  M. Merino,et al.  Intracystic papillary carcinoma of the breast after mastectomy, radiotherapy or excisional biopsy alone , 2006, Cancer.

[254]  J. LoGerfo Explorations in Quality Assessment and Monitoring. Volume I: The Definitions of Quality and Approaches to its Assessment , 1981 .

[255]  C. Redmond,et al.  Histologic grading of breast cancer. , 1980, Pathology annual.

[256]  T. Beauchamp,et al.  Principles of biomedical ethics , 1991 .

[257]  E. Robecchi [Pathology of the breast]. , 1954, Minerva ginecologica.